Overview

ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the characteristics of the smoker who wants to quit and his/her treating physician, in addition to determine the safety and effectiveness of Champix in the real-world setting of smokers in routine clinical practice.
Details
Lead Sponsor:
Pfizer
Treatments:
Varenicline